ADAG 股價走勢圖
ADAG 股票價格預測
Adagene Inc
$4.14
-2.12%
$-0.09
收盤價：Aug 06, 16:00:00 GMT-4
$4.65
12.31%
$0.51
盤後：Aug 06, 20:00:00 GMT-4
返回
Adagene Inc (ADAG) 股票價格預測
關鍵數據
前收市價
$4.23
開盤價
$4.23
當日範圍
$3.95 - $4.65
52週區間
$1.3 - $4.85
交易量
299.2K
平均成交量
271.9K
股息收益率
--
每股盈餘 (TTM)
-0.30
市值
$307.2M
什麼是 ADAG？
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. The firm is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.
